The stock market has faced challenges in July, with the S&P 500 down approximately 0.8% and struggling to reach previous highs. Concerns over rising oil prices due to the ongoing Iran war and skepticism surrounding the sustainability of the artificial intelligence boom have contributed to market volatility.
In this context, Wolfe Research has recommended stocks that have consistently beaten earnings expectations and received positive revisions for 2026 earnings estimates. Analyst Chris Senyek emphasized that companies with strong recent performance and favorable earnings revisions are likely to offer resilient returns.
Notable mentions include BlackRock, which received an upgrade from JPMorgan following strong second-quarter earnings; UnitedHealth Group, which exceeded revenue and earnings forecasts, prompting Goldman Sachs to maintain an overweight rating; and Philip Morris International, which is gaining traction with its smoke-free products and received a buy rating from BTIG with a price target suggesting a 10% upside.
These companies are positioned to navigate the current market turbulence effectively